Med Tech Acquisition Corp MTACW
Institutional shares held
66,666
0
calls
0
puts
Total value of holdings
$14K
$0
calls
$0
puts
Market Cap
N/A
Institutional ownership
N/A
# of Institutions
1
We take great care to ensure that the data presented and summarized in this overview for MedTech Acquisition Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MTACW
View allLatest Institutional Activity in MTACW
Top Purchases
Top Sells
About MTACW
Insider Transactions at MTACW
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
James Emmett Young Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,762
+28.8%
|
-
|
|
Feb 18
2025
|
Sean Murphy Chief Manuf, Strategy&Bus Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
15,817
+16.66%
|
-
|
|
Feb 18
2025
|
Bryan F. Cox CHIEF OF RESEARCH |
BUY
Grant, award, or other acquisition
|
Direct |
11,450
+9.55%
|
-
|
|
Feb 18
2025
|
Jennifer Stevens CHIEF REGULATORY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,481
+20.01%
|
-
|
|
Feb 18
2025
|
Mary T Szela CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
21,089
+4.34%
|
-
|
|
Feb 18
2025
|
Richard Marshak Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,644
+12.35%
|
-
|
|
Feb 18
2025
|
Jodi Devlin Chief of Clinical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,272
+13.63%
|
-
|
|
Feb 05
2025
|
James Emmett Young Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
6,000
+16.67%
|
$30,000
$5.65 P/Share
|
|
Jan 30
2025
|
Mary T Szela CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
5,010
+1.12%
|
$25,050
$5.28 P/Share
|
|
Jan 29
2025
|
Mary T Szela CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
5,030
+1.13%
|
$25,150
$5.03 P/Share
|
|
Jan 28
2025
|
Mary T Szela CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
4,716
+1.07%
|
$23,580
$5.12 P/Share
|
|
Jan 28
2025
|
Sean Murphy Chief Manuf, Strategy&Bus Dev. |
BUY
Open market or private purchase
|
Indirect |
15,000
+7.05%
|
$75,000
$5.17 P/Share
|
|
Jan 27
2025
|
Mary T Szela CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
4,826
+1.11%
|
$24,130
$5.42 P/Share
|
|
Jan 27
2025
|
Mary T Szela CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+8.61%
|
-
|
|
Jan 27
2025
|
Sean Murphy Chief Manuf, Strategy&Bus Dev. |
BUY
Open market or private purchase
|
Indirect |
15,000
+7.59%
|
$75,000
$5.31 P/Share
|
|
Jan 27
2025
|
Sean Murphy Chief Manuf, Strategy&Bus Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+16.49%
|
-
|
|
Jan 27
2025
|
Bryan F. Cox CHIEF OF RESEARCH |
BUY
Grant, award, or other acquisition
|
Direct |
10,625
+9.87%
|
-
|
|
Jan 27
2025
|
Jodi Devlin Chief of Clinical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,625
+27.42%
|
-
|
|
Jan 27
2025
|
James Emmett Young Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
24,000
+50.0%
|
$120,000
$5.4 P/Share
|
|
Jan 27
2025
|
James Emmett Young Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+36.52%
|
-
|
Last 12 Months Summary
Buy / Acquisition
504K
Shares
From
16
Insiders
| Grant, award, or other acquisition | 326K shares |
|---|---|
| Open market or private purchase | 178K shares |
Sell / Disposition
30.3K
Shares
From
3
Insiders
| Open market or private sale | 30.3K shares |
|---|